Skip to main content

Published locations for Ixekizumab met psoriasis endpoints by week 12, with durable response at 60 weeks

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ixekizumab met psoriasis endpoints by week 12, with durable response at 60 weeks

User login

  • Reset your password
  • /content/ixekizumab-met-psoriasis-endpoints-week-12-durable-response-60-weeks
  • /edermatologynews/article/98640/psoriasis/ixekizumab-met-psoriasis-endpoints-week-12-durable-response
  • /internalmedicinenews/article/98640/psoriasis/ixekizumab-met-psoriasis-endpoints-week-12-durable
  • /rheumatologynews/article/98640/psoriasis/ixekizumab-met-psoriasis-endpoints-week-12-durable-response
  • /rheumatology/article/98640/psoriasis/ixekizumab-met-psoriasis-endpoints-week-12-durable-response-60
  • /internalmedicine/article/98640/psoriasis/ixekizumab-met-psoriasis-endpoints-week-12-durable-response
  • /dermatology/article/98640/psoriasis/ixekizumab-met-psoriasis-endpoints-week-12-durable-response-60
  • /rheumatology/psoriatic-arthritis-resource-center/article/98640/psoriasis/ixekizumab-met-psoriasis
  • /dermatology/psoriasiscollection/article/98640/psoriasis/ixekizumab-met-psoriasis-endpoints-week-12
  • /psoriatic-arthritis-icymi/article/98640/psoriasis/ixekizumab-met-psoriasis-endpoints-week-12-durable